Assignee
QUANTUM GENOMICS
FR·6 granted patents·2 pending applications·2 citations·filing 2012–2021
Top patents by PatentIndex Score
8 records- 0174US9340497B2Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)QUANTUM GENOMICS·Filed 2015·Granted May 17, 2016·1 cites·19 claims
- 0273US11192907B2Aminopeptidase A inhibitors and pharmaceutical compositions comprising the sameQUANTUM GENOMICS·Filed 2019·Granted Dec 7, 2021·1 cites·13 claims
- 0349US9278921B2Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysineQUANTUM GENOMICS·Filed 2013·Granted Mar 8, 2016·0 cites·3 claims
- 0449US2023233492A1Pharmaceutical combination comprising a brain aminopeptidase a inhibitor, a diuretic and a blocker of the systemic renin-angiotensin systemQUANTUM GENOMICS·Filed 2021·Application pending·0 cites
- 0546US11345658B2Compounds and compositions comprising the same for treating hypertension or heart failureQUANTUM GENOMICS·Filed 2020·Granted May 31, 2022·0 cites·18 claims
- 0645US9487477B2Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysineQUANTUM GENOMICS·Filed 2016·Granted Nov 8, 2016·0 cites·4 claims
- 0744US2021309677A1Novel aminophosphinic derivatives as aminopeptidase a inhibitorsQUANTUM GENOMICS·Filed 2019·Application pending·0 cites
- 0840US10959938B2Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agentQUANTUM GENOMICS·Filed 2012·Granted Mar 30, 2021·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →